AAAAAA

   
Results: 1-9 |
Results: 9
Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor
Authors: Mazumdar, A Wang, RA Mishra, SK Adam, L Bagheri-Yarmand, R Mandal, M Vadlamudi, RK Kumar, R
Citation: A. Mazumdar et al., Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor, NAT CELL BI, 3(1), 2001, pp. 30-37
Carboxymethyl benzylamide dextran and tamoxifen combination inhibits tumorgrowth and angiogenesis
Authors: Bagheri-Yarmand, R Hamma-Kourbali, Y Bissieres, P Morere, JF Crepin, M
Citation: R. Bagheri-yarmand et al., Carboxymethyl benzylamide dextran and tamoxifen combination inhibits tumorgrowth and angiogenesis, CLIN CANC R, 7(6), 2001, pp. 1805-1811
Breast carcinoma cell uptake and Biodistribution of Technetium99m-Carboxymethyl Benzylamide Dextran
Authors: Bagheri-Yarmand, R Moretti, JL Baba, K Ozker, K Jozefonvicz, J Crepin, M
Citation: R. Bagheri-yarmand et al., Breast carcinoma cell uptake and Biodistribution of Technetium99m-Carboxymethyl Benzylamide Dextran, ANTICANC R, 21(1A), 2001, pp. 373-378
Vascular endothelial growth factor 165 (VEGF(165)) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding toVEGF(165) and VEGF(165)center dot KDR complexes
Authors: Hamma-Kourbali, Y Vassy, R Starzec, A Le Meuth-Metzinger, V Oudar, O Bagheri-Yarmand, R Perret, G Crepin, M
Citation: Y. Hamma-kourbali et al., Vascular endothelial growth factor 165 (VEGF(165)) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding toVEGF(165) and VEGF(165)center dot KDR complexes, J BIOL CHEM, 276(43), 2001, pp. 39748-39754
Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells
Authors: Bagheri-Yarmand, R Mandal, M Taludker, AH Wang, RA Vadlamudi, RK Kung, HJ Kumar, R
Citation: R. Bagheri-yarmand et al., Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells, J BIOL CHEM, 276(31), 2001, pp. 29403-29409
Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function
Authors: Mandal, M Vadlamudi, R Nguyen, D Wang, RA Costa, L Bagheri-Yarmand, R Mendelsohn, J Kumar, R
Citation: M. Mandal et al., Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function, J BIOL CHEM, 276(13), 2001, pp. 9699-9704
Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta 1-mediated angiogenesis
Authors: Bagheri-Yarmand, R Vadlamudi, RK Wang, RA Mendelsohn, J Kumar, R
Citation: R. Bagheri-yarmand et al., Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta 1-mediated angiogenesis, J BIOL CHEM, 275(50), 2000, pp. 39451-39457
Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice
Authors: Bagheri-Yarmand, R Kourbali, Y Rath, AM Vassy, R Martin, A Jozefonvicz, J Soria, C Lu, H Crepin, M
Citation: R. Bagheri-yarmand et al., Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice, CANCER RES, 59(3), 1999, pp. 507-510
Effects of the binding of a dextran derivative on fibroblast growth factor2: Secondary structure and receptor-binding studies
Authors: Bittoun, P Bagheri-Yarmand, R Chaubet, F Crepin, M Jozefonvicz, J Fermandjian, S
Citation: P. Bittoun et al., Effects of the binding of a dextran derivative on fibroblast growth factor2: Secondary structure and receptor-binding studies, BIOCH PHARM, 57(12), 1999, pp. 1399-1406
Risultati: 1-9 |